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Available online 7 November 2014AbstractObjective: In this study we investigate the quantitative diffusion tensor imaging (DTI) changes of normal-appearing white matter (NAWM) in
patients with stage 0 asymptomatic HIV-1 associated dementia complex (HAD), and clinical factors contributing to it.
Materials and methods: Conventional magnetic resonance imaging (cMRI) and DTI were performed in 40 patients with stage 0 asymptomatic
HAD (24 patients with CD4þ counts <200 cells/mm3, 16 patients with CD4þ counts >200 cells/mm3) and 40 healthy volunteers with similar
gender/age. Quantitative DTI values-fractional anisotropy (FA)/apparent diffusion coefficient (ADC) of normal-appearing white matter
(NAWM) in frontal, parietal, temporal, occipital lobes, genu, splenium and body of the corpus callosum (CC), corona radiate (CR), centrum
semiovale (CSO), and anterior and posterior limbs of the internal capsule were measured and analyzed.
Results: The mean FA values were much lower and the mean ADC values were significantly higher in the CC body and CSO in stage 0 HAD
patients than in the controls (P < 0.05). In comparison with controls, the patients with stage 0 asymptomatic HAD had significantly higher ADC
values (P < 0.05) for frontal, parietal, occipital lobes, CC body, CR and CSO, FA values of the corresponding regions were reduced, but the
differences were not statistically significant (all P > 0.05). FA values were reduced and ADC values were higher in other white matter regions,
but did not show any significant difference between the two groups (P > 0.05). Significantly higher ADC values in the frontal and CR in patients
with CD4þ counts <200 cells/mm3 compared with the patients with CD4þ counts >200 cells/mm3 and the controls.
Conclusions: Quantitative DTI could help better evaluation of white matter abnormalities in stage 0 asymptomatic HAD, this may be helpful for
early and accurate prevention and treatment of HAD, and for preventing or reversing cognitive decline. The quantitative DTI value changes
indicated that in early phase of HAD there is a preferential occult injury of frontal lobe and CSO. Nadir CD4þ count may be a great risk for HAD.
© 2014BeijingYou’anHospital affiliated toCapitalMedical University. Production and hosting byElsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Patients infected with HIV-1 are at risk for cognitive
deterioration and progression to dementia (HIV-D). HIV-
associated dementia (HAD), the most severe form of HIV
induced CNS impairment, is clinically characterized by motor
disorders, behavioral changes and cognitive dysfunction that* Corresponding author. Tel: þ86 13520278511.
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the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).in the absence of therapy may lead to seizures, coma and death
within six months of onset. Conventional magnetic resonance
imaging (cMRI) has revealed gray matter atrophy and white
matter hyperintensities [1,2] in advanced HIV disease. In the
early stages of HIV infection, however, white matter abnor-
malities are unreliably detected on structural MR.
Diffusion tensor imaging (DTI) is sensitive to the micro-
structural integrity of tissue and can be used to obtain
noninvasive measurements of the apparent diffusion coeffi-
cient (ADC) and the fractional anisotropy (FA) of water
molecules in brain regions of interest (ROIs). DTI abnormal-
ities have been identified in HIV patients [3e11]. DTI. Production and hosting by Elsevier B.V. This is an open access article under
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significantly associated with dementia severity and with psy-
chomotor loss, a sensitive early marker of brain injury and
cognitive deterioration [12e14], the sensitivity and utility of
DTI to identify pathologic changes in patients with stage
0 HAD has been questioned. In the present study, we sought to
evaluate DTI changes of normal-appearing white matter
(NAWM) in patients with stage 0 asymptomatic HAD.
2. Methods2.1. SubjectsFrom June 2011 to May 2014, 40 stage 0 asymptomatic
HAD patients from Infectious Department of our hospital
(mean age 39.5 yr; 34 men and 6 women) and 40 seronegative
controls with similar ranges of age, education and gender were
enrolled. Prior to enrollment in the study, all participants
signed an informed consent, and the protocol was approved by
our institution and was screened and evaluated to ensure the
fulfillment of study criteria. Study exclusion criteria included
age less than 18, chronic neurologic disorders, current or past
opportunistic central nervous system (CNS) infection, psy-
chosis at study entry, or MR contraindications.
In the HIV-1 group, the probable mode of HIV-1 infection
was sexual contact for 29 patients, blood transfusion for 2
patients and the others were not known. Self-reported sero-
positivity was confirmed by enzyme-linked immunosorbant
assay and Western blot. Recent CD4þ cell counts, assessed
within 2 weeks of the scan (mean ± S.D.:
135.65 ± 160.88 cells/mm3), revealed that 24 patients had
CD4þ T cell counts below 200 cells/mm3, 16 patients had
CD4þ counts above 200 cells/mm3. All patients were not
receiving any antiretroviral treatment. All HIV-positive
subjects underwent detailed neurologic, neuropsychologi-
cal, and clinical assessments as described previously [15],
and were classified as stage 0 (normal mental and motor
function) by using the Memorial Sloan-Kettering (MSK)
staging for HIV-associated dementia [3]. All clinical data
were reviewed by a neurologist (N.S., 5 years experience)
and a neuropsychologist (O.S., 10 years experience), who
were blinded to the MR spectroscopic imaging results until a
consensus was reached.2.2. MR imaging and image processingMR scans were performed on a 3 T S Trio scanner with a
maximal gradient strength of 40 mT/m and a maximal slew
rate of 200 mT/(m ms). In addition to T1-and T2-weighted
structural sequences, a spin-echo DTI series (single shot
echo-planar diffusion tensor imaging, EPI) was acquired. The
following parameters were used to consistently acquire DTI
data from all participants: 4 mm thick slices, 1.2 mm inter-
slice spacing, matrix ¼ 128  128, FOV ¼ 23  23 cm,
TR ¼ 3300 ms, TE ¼ 90ms, no partial echoes, NEX ¼ 3.
Diffusion encoding gradients (b ¼ 0, 1000 mm/s2) were
applied in 20 non-collinear directions.Fractional anisotropy (FA) and apparent diffusion coeffi-
cient (ADC) maps were calculated, Round regions of interest
of uniform size (16 mm2) were manually drawn to assess FA
and ADC. Circular regions of interest (ROIs) were positioned
on the images in defined anatomical locations. Fig. 1 shows
examples of ROI positioning on the FA images. In addition to
the genu and splenium of the corpus callosum (CC), the
following regions were evaluated in both right and left
hemispheres: frontal, parietal, temporal, occipital lobes, body
of the CC, corona radiate (CR), centrum semiovale (CSO),
anterior and posterior limbs of the internal capsule. The lat-
eralized measures were then averaged for further analysis. One
experienced reviewer who was blinded to the HIV status of the
patients performed the measurements.2.3. Statistical analysisDescriptive statistical analysis included the calculation of
means and SDs of the obtained data. All FA and ADC mea-
surements obtained in HIVþ patients were then compared
with those of the controls. Statistical analysis was performed
by using the t test. Analyses of variance (ANOVA) was used
for the controls and patients grouped in different categories
depending on their CD4 cell counts. All statistical tests were
2-tailed, using a significant level of 0.05, and were executed in
SPSS (release 17.0; SPSS, Inc., Chicago, Ill).
3. Results
The FA values were significantly lower in the CC body and
CSO in stage 0 HAD patients than in the controls (P < 0.05)
(Table 1). FA values were reduced in the frontal, parietal,
temporal, occipital lobes, genu and splenium of the corpus
callosum, corona radiate, anterior and posterior limb of the
internal capsule in stage 0 HAD patients compared with
controls, but all the differences were not statistically signifi-
cant (all P > 0.05).
In comparison with controls, the patients with asymptom-
atic HAD had significantly higher ADC values for frontal,
parietal, occipital lobes, CC body, corona radiate and CSO
(P < 0.05) (Table 2); ADC values were higher in temporal
lobe, genu and splenium of the corpus callosum, anterior and
posterior limb of the internal capsule regions, but did not show
any significant difference between the two groups (P > 0.05).
Tables 3 and 4 summarize FA and ADC values measured in
the white matter regions of the brain in 3 groups with different
CD4þ levels (CD4þ counts <200 cells/mm3, CD4þ counts
>200 cells/mm3 and controls). FAwas reduced in all the ROIs
in patients with CD4þ counts <200 cells/mm3 compared with
the patients with CD4þ counts >200 cells/mm3, but they did
not reach the level of statistical significance (all P > 0.05).
Furthermore, no statistically significant differences were found
in FA values between the patients with CD4þ counts
<200 cells/mm3 and the controls in all the ROIs except for
CSO (P < 0.05) (Table 3).
Significantly higher ADC values in the frontal lobe and
corona radiate in patients with CD4þ counts <200 cells/mm3
Fig. 1. ROI positions on fractional anisotropy images. A: temporal lobe and occipital lobe; B: frontal lobe, parietal lobe, genu and splenium of the corpus callosum,
anterior and posterior limbs of the internal capsule; C: body of the corpus callosum, corona radiate; D: centrum semiovale.
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and the controls (P < 0.05) (Table 4). ADC values were higher
in others white matter in patients with CD4þ counts
<200 cells/mm3 compared with the patients with CD4þ counts
>200 cells/mm3, without statistically significant differences
(all P > 0.05). There were statistically significant differences
were found in ADC values between the patients with CD4þ
counts <200 cells/mm3 and the controls in the frontal lobe,
parietal lobe, occipital lobe, CC body, corona radiate and CSO
(all P < 0.05), the other regions did not show significant
differences.
4. Discussion
Clinically, HIV brain infection manifests as neuro-
psychologic impairment that ranges from mild cognitive motor
disorder to HAD. AIDS dementia complex occurs during the
later stages of AIDS and predominantly affects the white
matter by producing demyelination and gliosis. Before
HAART was available, the median survival time of an AIDS
dementia complex patient after the onset of dementia was 6months. Although AIDS patients have improved survival rates
because of antiretroviral therapy, the number of new AIDS
dementia complex cases had declined, approximately 30%e
50% of these patients develop AIDS dementia complex
[12,16e18].
The diagnosis of HAD is based on the clinical findings of
CNS neurologic dysfunction, the early symptoms are often
subtle and may be confused with psychiatric complaints or
overlooked. Radiologic studies are important in HAD patients
to exclude other infections and tumors. The imaging findings
of AIDS dementia complex are frequently referred to as at-
rophy and HIV encephalitis [1,2,19e21]. MR imaging ab-
normalities include multiple discrete foci, patchy areas of
confluent involvement, or symmetric diffuse parenchymal
involvement within the periventricular and deep white matter
observed on long-TR images, this indicates an advanced stage
of the disease. The principal advantage of DTI is quantitative
sensitivity to changes that may not be detected with conven-
tional T1-, T2-weighted magnetic resonance imaging.
Diffusion alterations have been identified in subjects in
more advanced stages of HIV infection [9e14]. The earlier we
Table 3
FA values in different white matter regions in stage 0 HAD patients and
controls according to the CD4þ count (x±s).
ROIs Groups
Stage 0 HAD CD4þ count Controls F value P value
<200 >200
Frontal 0.489 ± 0.068 0.517 ± 0.065 0.519 ± 0.067 1.494 0.231
Parietal 0.488 ± 0.047 0.513 ± 0.074 0.518 ± 0.075 1.554 0.218
Temporal 0.465 ± 0.046 0.474 ± 0.067 0.481 ± 0.043 0.826 0.442
Occipital 0.570 ± 0.057 0.577 ± 0.051 0.596 ± 0.050 1.855 0.163
CC genu 0.804 ± 0.079 0.817 ± 0.046 0.827 ± 0.046 1.218 0.301
Splenium 0.832 ± 0.222 0.879 ± 0.052 0.885 ± 0.042 1.490 0.232
Body 0.802 ± 0.048 0.806 ± 0.035 0.823 ± 0.036 2.615 0.080
CR 0.492 ± 0.040 0.511 ± 0.036 0.512 ± 0.056 1.445 0.242
CSO 0.440 ± 0.034 0.443 ± 0.035 0.475 ± 0.045a 2.475 0.002
ALIC 0.657 ± 0.065 0.663 ± 0.065 0.663 ± 0.031 0.123 0.884
PLIC 0.694 ± 0.055 0.699 ± 0.044 0.703 ± 0.034 0.209 0.812
Note: CC, corpus callosum; CR, corona radiate; CSO, centrum semiovale;
ALIC, anterior limb of the internal capsule; PLIC posterior limb of the internal
capsule.
a There was significant difference between the patients with CD4þ <200/
mm3 group and the controls.
Table 1
FA values in different white matter regions in stage 0 HAD patients and
controls (x±s).
ROIs Groups
Stage 0 HAD (n ¼ 32) Controls (n ¼ 29) t value P value
frontal 0.501 ± 0.068 0.517 ± 0.065 1.060 0.293
parietal 0.498 ± 0.060 0.519 ± 0.075 1.340 0.184
temporal 0.468 ± 0.055 0.481 ± 0.043 1.156 0.251
occipital 0.574 ± 0.053 0.596 ± 0.050 1.895 0.062
CC genu 0.809 ± 0.068 0.827 ± 0.046 1.397 0.166
splenium 0.860 ± 0.145 0.884 ± 0.042 1.009 0.316
body 0.803 ± 0.043 0.823 ± 0.036 2.278 0.025*
CR 0.499 ± 0.039 0.512 ± 0.056 1.137 0.259
CSO 0.442 ± 0.034 0.475 ± 0.045 3.660 0.000*
ALIC 0.661 ± 0.056 0.663 ± 0.031 0.201 0.841
PLIC 0.698 ± 0.047 0.699 ± 0.044 0.146 0.884
Note: *P < 0.05; CC, corpus callosum; CR, corona radiate; CSO, centrum
semiovale; ALIC, anterior limb of the internal capsule; PLIC posterior limb of
the internal capsule.
Table 4
ADC values in different white matter regions in stage 0 HAD patients and
controls according to the CD4þ count (x±s).
14 R. Li et al. / Radiology of Infectious Diseases 1 (2014) 11e16can detect HIV-related brain injury with imaging techniques
(especially when the patient is still asymptomatic), the sooner
clinicians can consider starting antiretroviral therapy. With the
knowledge that there is no reliable clinical method for early
detection of HIV-related brain injury exists, the search for a
reliable imaging technique is, thus, still necessary. In this
investigation, we sought to assess whether DTI can detect
subtle white matter abnormalities in earlier disease stages and
to determine the potential functional implications of micro-
structural white matter abnormalities in HIV-1 disease, such as
stage 0 asymptomatic HAD patients.
In this study, ROI based comparisons of DTI between
normal control subjects and stage 0 asymptomatic HAD
support the following major findings: 1) HIV infection causes
abnormalities in normal-appearing white matter (NAWM). In
comparison with controls, the patients with stage 0 asymp-
tomatic HAD had significantly lower FA values in the CC
body and CSO, significantly higher ADC values (P < 0.05)
for frontal, parietal, occipital lobes, CC body, corona radiateTable 2
ADC values in different white matter regions in stage 0 HAD patients and
controls (x±s).
ROIs Groups
Stage 0 HAD (n ¼ 32) Controls (n ¼ 29) t value P value
Frontal 0.791 ± 0.059 0.754 ± 0.033 3.450 0.001*
Parietal 0.770 ± 0.052 0.740 ± 0.029 3.188 0.002*
Temporal 0.832 ± 0.051 0.816 ± 0.071 1.188 0.238
Occipital 0.824 ± 0.054 0.786 ± 0.068 2.750 0.007*
CC genu 0.825 ± 0.069 0.801 ± 0.047 1.844 0.069
Splenium 0.757 ± 0.059 0.747 ± 0.053 0.784 0.435
Body 0.785 ± 0.046 0.762 ± 0.033 2.651 0.010*
CR 0.757 ± 0.036 0.726 ± 0.028 4.248 0.000*
CSO 0.773 ± 0.025 0.755 ± 0.028 3.153 0.002*
ALIC 0.730 ± 0.028 0.722 ± 0.034 1.154 0.252
PLIC 0.733 ± 0.035 0.730 ± 0.028 0.441 0.660
Note: *P < 0.05; CC, corpus callosum; CR, corona radiate; CSO, centrum
semiovale; ALIC, anterior limb of the internal capsule; PLIC posterior limb of
the internal capsule.and CSO. There is a trend to lower FA and higher ADC in the
other widespread white matter, though without statistically
significant differences. These results imply that AIDS pa-
tients may have abnonllalities in the diffusion of water
molecules in their brain white matter when they don't have
any symptoms, and demonstrate that DTI could sensitively
detect early pathological changes, such as demyelination and
gliosis in white matter. In general, the identified white matter
abnormalities in our study agree with previous HIV studies.
In the ROI based study by Xuan A [22] et al., in the
asymptomatic AIDS patients group, the mean FA values were
significantly lower and the mean ADC values wereROIs Groups
Stage 0 HAD CD4þ count Controls F value P value
<200 >200
Frontal 0.807 ± 0.059 0.768 ± 0.052a 0.754 ± 0.033b 10.031 0.000
Parietal 0.773 ± 0.062 0.768 ± 0.045 0.740 ± 0.029b 5.106 0.008
Temporal 0.838 ± 0.058 0.824 ± 0.040 0.816 ± 0.071 0.921 0.402
Occipital 0.843 ± 0.048 0.811 ± 0.056 0.786 ± 0.068b 5.160 0.008
CC genu 0.828 ± 0.078 0.821 ± 0.054 0.801 ± 0.060 1.737 0.183
Splenium 0.757 ± 0.065 0.771 ± 0.049 0.747 ± 0.053 0.305 0.738
Body 0.788 ± 0.056 0.780 ± 0.025 0.762 ± 0.033b 3.694 0.029
CR 0.769 ± 0.034 0.740 ± 0.032a 0.726 ± 0.028b 14.185 0.000
CSO 0.775 ± 0.026 0.772 ± 0.024 0.755 ± 0.028b 4.966 0.009
ALIC 0.737 ± 0.028 0.722 ± 0.034 0.719 ± 0.025 2.247 0.113
PLIC 0.743 ± 0.035 0.730 ± 0.028 0.718 ± 0.031b 3.395 0.039
Note: CC, corpus callosum; CR, corona radiate; CSO, centrum semiovale;
ALIC, anterior limb of the internal capsule; PLIC posterior limb of the internal
capsule.
a There was significant difference between the patients with CD4þ <200/
mm3 group and the patients with CD4þ >200/mm3 group.
b There was significant difference between the patients with CD4þ <200/
mm3 group and the controls.
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periventricular white matter, frontal lobe white matter and
parietal lobe white matter， than in the control group. In the
voxelwise-based study by Leite SC [23] et al., they found that
in the body of corpus callosum the FA was significantly
reduced. FA value and ADC value, which is more sensitive to
changes of white matter in HIV þ patients is an contradiction
at previous reports. We found HIV þ infection affects ADC
to a greater extent than FA, which may suggest that alteration
of ADC may reflect the prominent disease process in
HIV þ patients, this is consistent with the findings of Zhu T
et al. [24], they reported that mean diffusivity (MD) increased
significantly in the both hemispheres in HIV patients with
neurologically asymptomatic compared to controls, no sta-
tistical significance was detected in any regions in FA.
Otherwise, Stubbe-Drger B et al. [3,5,10] suggested that FA
could be more sensitive than other MRI approaches to
microstructural white matter abnormalities. This may be due
to the differences in patients receiving HAART or not, in our
study, all patients were not receiving any antiretroviral
treatment, their participants were on a stable antiretroviral
regimen for at least 12 consecutive weeks prior to study,
based on this inconsistency, we will continue to study the
effects of HAART on white matter DTI parameters of HIV
patients. 2) The frontal lobe white matter and CSO may be
subject to early injury in patients infected with HIV, and this
agrees with previous HIV studies [3,5,10,22,24,25]. Smith
AB et al. [25] reported that there is a frontal lobe white
matter predominant involvement in HIV infection of the
brain. MR spectroscopy studies [26] also indicate that frontal
lobe white matter may be subject to early injury in patients
infected with HIV. The results suggest that selective micro-
structural white matter damage could be revealed in pa-
tients with HAD, the damage could be appeared firstly in the
cerebral regions serving higher cortical functions (frontal,
parietal lobes). 3) We have used parameters obtainable from
DTI to try to establish a relationship between HIV þ patients
on the basis of their CD4þ cell counts when compared with
normal individuals. Significantly higher ADC values in the
frontal lobe and corona radiate in patients with CD4þ counts
<200 cells/mm3 compared with the patients with CD4þ
counts >200 cells/mm3 and the controls. The white matter
alteration in patients with CD4þ counts less than 200 cells/
mm3 is more severe than patients with CD4þ counts more
than 200 cells/mm3 suggesting the patients with CD4þ counts
less than 200 cells/mm3 is at most risk for developing AIDS
dementia complex [20,27]. The largest decrease in anisotropy
was in the corpus callosum of patients with advanced HIV
disease and with the lowest CD4þ counts as were found in a
previously published study [28]. This is also in accordance
with findings from MR spectroscopy studies of HIV disease.
Lower CD4þ T-cell counts have been associated with ele-
vations in frontal white matter Cho, Cr, and myo -inositol
levels (glial and energy-associated metabolites) [29].
Elevated Cho scores in these subjects correlated with a
decline in CD4þ T-cell counts. Another recently published
study [30] demonstrated a different conclusion, FA and ADCvalues measured in HIV＋ patients did not differ much in
different CD4þ counts groups, furthermore, they did not find
statistically significant differences when correlation between
different CD4þ counts groups and controls were performed.
This may be due to the differences in patient populations and
modes of HIV-1 infection.
5. Conclusion
Our initial experience with analyzing brain abnormality in
stage 0 asymptomatic HAD patients with multiple DTI pa-
rameters is promising. Our results support that abnormalities
in normal-appearing white matter (NAWM) in stage
0 asymptomatic HAD patients. Furthermore, the frontal lobe
white matter and CSO may be an earliest region of interest for
monitoring changes in HIV infection, and there is a trend to
lower FA and higher ADC in the widespread white matter
when compared with controls, though without statistically
significant differences. In addition, nadir CD4þ count is a risk
factor for progression to HAD. DTI is sensitivity to detection
of disruption of microstructural integrity of white matter may
allow early indication of the potential for HAD.
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